Replies to post #235890 on Biotech Values

[DewDiligence]

FDA approves MYOV’s Orgovyx (relugolix) for prostate cancer:

https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-hormone-therapy-treating-advanced-prostate-cancer

An oral option for androgen deprivation is especially useful during a pandemic.